We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$194M
AUM Growth
-$8.89M
Cap. Flow
+$19.3M
Cap. Flow %
9.92%
Top 10 Hldgs %
45.72%
Holding
105
New
22
Increased
26
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.12M
2
BNED icon
Barnes & Noble Education
BNED
+$2.68M
3
SLV icon
iShares Silver Trust
SLV
+$2.54M
4
BHVN icon
Biohaven
BHVN
+$2.04M
5
ZM icon
Zoom
ZM
+$1.84M

Top Sells

Rank Stock Value
1
PAAS icon
Pan American Silver
PAAS
+$679K
2
AMGN icon
Amgen
AMGN
+$529K
3
ORCL icon
Oracle
ORCL
+$497K
4
YETI icon
Yeti Holdings
YETI
+$482K
5
ALT icon
Altimmune
ALT
+$394K

Sector Composition

Rank Sector Weight
1 Healthcare 33.59%
2 Technology 24.43%
3 Miscellaneous 16.75%
4 Communication Services 9.68%
5 Consumer Discretionary 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHOP icon
76
CALL
Shopify
SHOP
$165B
$264K 0.14%
+4,000
New +$265K
SHOP icon
77
Shopify
SHOP
$165B
$264K 0.14%
+4,000
New +$265K
JFR icon
78
Nuveen Floating Rate Income Fund
JFR
$1.21B
$255K 0.13%
+29,500
New +$257K
TEVA icon
79
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
$244K 0.13%
15,000
-7,500
-33% -$116K
BIIB icon
80
Biogen
BIIB
$32.4B
$232K 0.12%
+1,000
New +$217K
VRDN icon
81
Viridian Therapeutics
VRDN
$2.48B
$231K 0.12%
17,750
+3,250
+22% +$45K
ZBH icon
82
CALL
Zimmer Biomet
ZBH
$18B
$217K 0.11%
+2,000
New +$236K
NOK icon
83
Nokia
NOK
$59.3B
$189K 0.1%
50,000
– –
ARQ icon
84
Arq
ARQ
$90M
$134K 0.07%
22,000
+6,000
+38% +$41.4K
LCTX icon
85
Lineage Cell Therapeutics
LCTX
$260M
$107K 0.06%
107,751
– –
BHVN icon
86
PUT
Biohaven
BHVN
$2.1B
$52.1K 0.03%
+1,500
New +$59.3K
TBHC
87
DELISTED
The Brand House Collective
TBHC
$41.4K 0.02%
25,415
– –
OVID icon
88
Ovid Therapeutics
OVID
$527M
$32.1K 0.02%
41,750
+22,020
+112% +$61.3K
IONS icon
89
CALL
Ionis Pharmaceuticals
IONS
$7.77B
$23.8K 0.01%
+500
New +$20.5K
EQ icon
90
Equillium
EQ
$120M
$22.8K 0.01%
+32,962
New +$47.1K
ESPR
91
CALL
DELISTED
Esperion Therapeutics
ESPR
$555 ﹤0.01%
250
-3,250
-93% -$7.64K
AMRN
92
Amarin Corp
AMRN
$293M
– –
-665
Closed -$11.8K
BIDU icon
93
CALL
Baidu
BIDU
$30.7B
– –
-1,000
Closed -$105K
GLD icon
94
PUT
SPDR Gold Trust
GLD
$147B
– –
-5,000
Closed -$1.03M
MU icon
95
PUT
Micron Technology
MU
$1.1T
– –
-4,000
Closed -$472K
PAAS icon
96
Pan American Silver
PAAS
$20.6B
– –
-45,000
Closed -$679K
QQQ icon
97
PUT
Invesco QQQ Trust
QQQ
$482B
– –
-20,000
Closed -$8.88M
SPYM
98
CALL
State Street SPDR Portfolio S&P 500 ETF
SPYM
$162B
– –
-2,500
Closed -$154K
SPYM
99
PUT
State Street SPDR Portfolio S&P 500 ETF
SPYM
$162B
– –
-60,000
Closed -$3.69M
SPY icon
100
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$804B
– –
-40,500
Closed -$21.2M
1 2 3
4
5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, DCF Advisers held 105 positions worth $194M, down 4.4% from $203M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

DCF Advisers deployed $19.3M of net new capital in Q2 2024, opening 22 new positions and adding to 26 existing holdings. Its largest new stake was Amazon: 17,000 shares worth $3.29M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Amgen, an estimated $529K trimmed.

  • DCF Advisers's largest Q2 2024 buy was Amazon: 17,000 shares worth $3.29M.
  • DCF Advisers added most to iShares Silver Trust in Q2 2024, an estimated $2.54M increase.
  • DCF Advisers's biggest Q2 2024 reduction was Amgen, cutting an estimated $529K.
  • DCF Advisers fully exited Pan American Silver in Q2 2024, selling an estimated $679K.
  • DCF Advisers's ten largest holdings make up 46% of its $194M portfolio in Q2 2024.
  • DCF Advisers opened 22 new positions and closed 11 in Q2 2024.
  • DCF Advisers's portfolio value fell 4.4% quarter-over-quarter to $194M.

Based on DCF Advisers's 13F filing for Q2 2024, filed 12 Aug 2024.